Indicators

Latest News about CTLT

Recent news which mentions CTLT

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Dow, Nasdaq Futures Lower Following Friday's Sell-Off; US Dollar Surges To 20-Year High

August 29, 2022

Earnings Scheduled For August 29, 2022

August 29, 2022

Catalent, Pinduoduo And 3 Stocks To Watch Heading Into Monday

August 29, 2022

Bitcoin Tumbles Below This Major Level Following Powell's Remarks; Here Are The Top Crypto Movers For Monday

August 29, 2022

Catalent's Earnings: A Preview

August 26, 2022

Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says

August 12, 2022

Catalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: Report

August 10, 2022

Quant Ratings Updated on 75 Stocks

May 26, 2022

Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know

May 04, 2022

80 Biggest Movers From Yesterday

May 04, 2022

Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook

May 03, 2022

41 Stocks Moving In Tuesday's Mid-Day Session

May 03, 2022

Catalent (CTLT) Q3 2022 Earnings Call Transcript

May 03, 2022

Recap: Catalent Q3 Earnings

May 03, 2022

Why Erytech Pharma Are Shares Moving Higher Today

April 25, 2022

How To Attend Catalent Q3 2022 Earnings Conference Call

April 21, 2022

24 Biggest Movers From Yesterday

April 13, 2022

Markets Fall As Investors Weigh March CPI Report

April 12, 2022

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout

March 22, 2022

Novo Nordisk Doubles 2025 Sales Target On Strong Wegovy Demand

March 03, 2022

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows

February 21, 2022

Executives Sell More Than $210M Of 5 Stocks

February 09, 2022

Only 29 stocks hit all 4 of these key metrics so far this earnings season

February 07, 2022

Catalent (CTLT) Q2 2022 Earnings Call Transcript

February 01, 2022

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program

February 01, 2022

Catalent's Q2 Earnings Beat Street View, Lifts FY22 Guidance

February 01, 2022

A Bearish Sign Appears On Catalent's Chart

January 31, 2022

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News

January 31, 2022

Expert Ratings For Catalent

January 27, 2022

This is the window of time when value can outperform growth in the stock market

January 18, 2022

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.